Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data

There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.

Cook Medical has just announced the release of de-identifiable patient-level data for the ZILVER PTX randomised controlled trial. CX Live spoke to Michael Dake (Tucson, USA), Gary Ansel (Columbus, USA) and Aaron Lottes (West Lafayette, USA) on why this is an important step and on the highlights of the Zilver PTX five-year safety and mortality data.

For more information about Zilver PTX, and to request the patient-level data, visit

This video is sponsored by Cook Medical.

Dake, Michael

Dr. Michael D. Dake, an internationally recognized physician-scientist, health educator and innovative medical researcher and the senior vice president for health sciences at the University of Arizona.

Add comment

Editor’s Peripheral Pick

    Subscribe to receive the very best in medical videos

    /* ]]> */